In stock A Long-Acting Amylin Analogue for Advanced Metabolic Research Cagrilintide is an investigational long-acting amylin analogue developed for advanced metabolic and endocrine research applications
The table below outlines clinical and operational distinctions
Its active ingredient, synthetic deoxycholic acid , ruptures the cell membrane , leading to the death of the targeted fat cells
More serious side effects may occur and should be discussed with a healthcare provider
Other oral are in FDA review and could hit the market in 2024
Specifications Scientific Name CJC-1295 (Modified GRF 1-29) + Ipamorelin: Two-Peptide Research Blend CAS Number 446036-97-1 / 170851-70-4 Molecular Formula CJC-1295 CHNO Ipamorelin CHNO Molecular Weight Blend: CJC-1295 (no DAC) 3,367.9 g/mol Ipamorelin 711.9 g/mol Physical Form Lyophilized powder Purity Coming Soon Storage 20C, protected from light, avoid repeated freeze-thaw cycles Storage & Handling Store per the product label and available manufacturer handling documentation, and follow standard laboratory protocols for handling